EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sulindac prevents increased mitochondrial VDAC1 expression and cell surface mistargeting induced by pathological conditions in retinal cells

Mohammad Tariq, Marie Sjögren, Albert Salehi

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Mohammad Tariq und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, SUS, Division of Islet Cell Physiology, Lund University, Malmö, Sweden. Hauptthemen laut MEDLINE: Voltage-Dependent Anion Channel 1, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) continues to be the primary cause of vision loss in poorly controlled diabetic subjects. The molecular mechanisms underlying retinal pigment epithelium (RPE) cell dysfunction in DR still remain elusive. We investigated the role of mitochondrial volt-age-dependent anion channel 1 (VDAC1) in RPE dysfunction under glucotoxic and inflammatory conditions. Our results demonstrate that both glucotoxicity and cytokine treatment reduces cellular viability accompanied by increased VDAC1 and inducible nitric oxide synthase (iNOS) expression, concomitant with decreased expression of mitochondrial VDAC2 and constitutively ex-pressed endothelial NOS (eNOS). Increased VDAC1 expression during these conditions leads to its mistargeting to the cell surface, leading to ATP loss. Additionally, VDAC1 upregulation by glucotoxicity and inflammatory cytokines induces leakage of mitochondrial DNA (mtDNA) into the cytosol. Sulindac, a nonsteroidal anti-inflammatory agent, mitigates the adverse effects associated with increased VDAC1 level under pathophysiological conditions, by suppressing VDAC1 expression. The effect of sulindac on restoring cell viability could be comparably achieved only with VDAC1 inhibitor (VBIT-4) or VDAC1-specific antibody and not with the iNOS inhibitor aminoguanidine. Our findings suggest that sulindac's beneficial effects on ARPE-19 cell function are mediated by prevention of increased VDAC1 expression under pathological conditions, thus preventing mtDNA leakage and ATP loss, which are the key steps in induction of cellular inflammatory responses involved in the development of DR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Voltage-Dependent Anion Channel 1MitochondriaHumansNitric Oxide Synthase Type IIRetinal Pigment EpitheliumCell SurvivalCell LineAnti-Inflammatory Agents, Non-SteroidalDiabetic RetinopathyDNA, MitochondrialGlucose

Substanzen

Voltage-Dependent Anion Channel 1VDAC1 protein, humanNitric Oxide Synthase Type IIAnti-Inflammatory Agents, Non-SteroidalDNA, MitochondrialGlucose

Autor:innen und Institutionen

  • Department of Clinical Science, SUS, Division of Islet Cell Physiology, Lund University, Malmö, Sweden.
  • Department of Clinical Science, SUS, Division of Islet Cell Physiology, Lund University, Malmö, Sweden. Electronic address: S_Albert.Salehi@med.lu.se.

Zitieren

APA

Tariq, M., Sjögren, M., & Salehi, A. (2024). Sulindac prevents increased mitochondrial VDAC1 expression and cell surface mistargeting induced by pathological conditions in retinal cells. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150558

Vancouver

Tariq M, Sjögren M, Salehi A. Sulindac prevents increased mitochondrial VDAC1 expression and cell surface mistargeting induced by pathological conditions in retinal cells. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150558

BibTeX
@article{Tariq2024,
  author = {Tariq, Mohammad and Sjögren, Marie and Salehi, Albert},
  title = {Sulindac prevents increased mitochondrial VDAC1 expression and cell surface mistargeting induced by pathological conditions in retinal cells},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150558}
}
Kostenlos starten →